Role of MR imaging of uterine leiomyomas before and after embolization

Radiographics

Volumn 32, Issue 6, 2012, Pages

  Deshmukh, Sandeep P ^a   Gonsalves, Carin F ^a   Guglielmo, Flavius F ^a   Mitchell, Donald G ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HUMAN; LEIOMYOMA; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; UTERUS CANCER;

EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LEIOMYOMA; MAGNETIC RESONANCE IMAGING; UTERINE NEOPLASMS;

EID: 84867593515     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.326125517     Document Type: Article

References (71)

1. Becker ER, Spalding J, DuChane J, Horowitz IR. Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998-2002. J Natl Med Assoc 2005;97(10):1336-1342.
2. Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: an update of the evidence. Evidence report/technology assessment no. 154, AHRQ publication no. 07-E011. Rockville, Md: Agency for Healthcare Research and Quality, 2007.
3. Parker WH. Myomectomy: laparoscopy or laparotomy? Clin Obstet Gynecol 1995;38(2):392-400.
4. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981;36(4):433-445.
5. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172(1 pt 1):14-18.
6. Goodwin SC, Vedantham S, McLucas B, Forno AE, Perrella R. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol 1997;8(4):517-526.
7. Schwartz LB, Panageas E, Lange R, Rizzo J, Comite F, McCarthy S. Female pelvis: impact of MR imaging on treatment decisions and net cost analysis. Radiology 1994;192(1):55-60.
8. Jha RC, Ascher SM, Imaoka I, Spies JB. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology 2000;217(1):228-235.
9. Katsumori T, Akazawa K, Mihara T. Uterine artery embolization for pedunculated subserosal fibroids. AJR Am J Roentgenol 2005;184(2):399-402.
10. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188 (1):100-107.
11. Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 2004;159(2): 113-123.
12. Prayson RA, Hart WR. Pathologic considerations of uterine smooth muscle tumors. Obstet Gynecol Clin North Am 1995;22(4):637-657.
13. Gompel C, Silverberg SG. The corpus uteri. In: Gompel C, Silverberg SG, eds. Pathology in gynecology and obstetrics. Philadelphia, Pa: Lippincott, 1994; 163-283.
14. Novak ER, Woodruff JD. Myoma and other benign tumors of the uterus. In: Novak ER, Woodruff JD, eds. Novak's gynecologic and obstetric pathology. Philadelphia, Pa: Saunders, 1979; 260-279.
15. Okizuka H, Sugimura K, Takemori M, Obayashi C, Kitao M, Ishida T. MR detection of degenerating uterine leiomyomas. J Comput Assist Tomogr 1993;17(5):760-766.
16. Kim MD, Lee M, Jung DC, et al. Limited efficacy of uterine artery embolization for cervical leiomyomas. J Vasc Interv Radiol 2012;23(2):236-240.
17. Garcia CR, Tureck RW. Submucosal leiomyomas and infertility. Fertil Steril 1984;42(1):16-19.
18. Corson SL. Hysteroscopic diagnosis and operative therapy of submucous myoma. Obstet Gynecol Clin North Am 1995;22(4):739-755.
19. Ben-Baruch G, Schiff E, Menashe Y, Menczer J. Immediate and late outcome of vaginal myomectomy for prolapsed pedunculated submucous myoma. Obstet Gynecol 1988;72(6):858-861.
20. Panageas E, Kier R, McCauley TR, McCarthy S. Submucosal uterine leiomyomas: diagnosis of prolapse into the cervix and vagina based on MR imaging. AJR Am J Roentgenol 1992;159(3):555-558.
21. Hutchins FL Jr. Uterine fibroids: diagnosis and indications for treatment. Obstet Gynecol Clin North Am 1995;22(4):659-665.
22. Stewart EA. Uterine fibroids. Lancet 2001;357 (9252):293-298.
23. Hricak H, Tscholakoff D, Heinrichs L, et al. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology 1986;158(2): 385-391.
24. Dudiak CM, Turner DA, Patel SK, Archie JT, Silver B, Norusis M. Uterine leiomyomas in the infertile patient: preoperative localization with MR imaging versus US and hysterosalpingography. Radiology 1988;167(3):627-630.
25. Kawakami S, Togashi K, Konishi I, et al. Red degeneration of uterine leiomyoma: MR appearance. J Comput Assist Tomogr 1994;18(6):925-928.
26. Mittl RL Jr, Yeh IT, Kressel HY. High-signal-intensity rim surrounding uterine leiomyomas on MR images: pathologic correlation. Radiology 1991; 180(1):81-83.
27. Hricak H, Finck S, Honda G, Göranson H. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images. AJR Am J Roentgenol 1992;158 (5):1043-1050.
28. Novak ER, Woodruff JD. Adenomyosis (adenomyoma) uteri. In: Novak ER, Woodruff JD, eds. Novak's gynecologic and obstetric pathology. Philadelphia, PA: Saunders, 1979; 280-290.
29. Mark AS, Hricak H, Heinrichs LW, et al. Adenomyosis and leiomyoma: differential diagnosis with MR imaging. Radiology 1987;163(2):527-529.
30. Reinhold C, McCarthy S, Bret PM, et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology 1996;199(1):151-158.
31. Outwater EK, Siegelman ES, Van Deerlin V. Adenomyosis: current concepts and imaging considerations. AJR Am J Roentgenol 1998;170(2):437-441.
32. Togashi K, Ozasa H, Konishi I, et al. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology 1989;171 (2):531-534.
33. Scoutt LM, McCarthy SM, Lange R, Bourque A, Schwartz PE. MR evaluation of clinically suspected adnexal masses. J Comput Assist Tomogr 1994;18 (4):609-618.
34. Weinreb JC, Barkoff ND, Megibow A, Demopoulos R. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. AJR Am J Roentgenol 1990;154(2):295-299.
35. Outwater EK, Siegelman ES, Talerman A, Dunton C. Ovarian fibromas and cystadenofibromas: MRI features of the fibrous component. J Magn Reson Imaging 1997;7(3):465-471.
36. Outwater EK, Siegelman ES, Kim B, Chiowanich P, Blasbalg R, Kilger A. Ovarian Brenner tumors: MR imaging characteristics. Magn Reson Imaging 1998;16(10):1147-1153.
37. Togashi K, Kawakami S, Kimura I, et al. Sustained uterine contractions: a cause of hypointense myometrial bulging. Radiology 1993;187(3):707-710.
38. Rha SE, Byun JY, Jung SE, et al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003;181(5):1369-1374.
39. Pattani SJ, Kier R, Deal R, Luchansky E. MRI of uterine leiomyosarcoma. Magn Reson Imaging 1995;13(2):331-333.
40. Janus CJ, White M, Dottino P, Brodman M, Goodman H. Uterine leiomyosarcoma: magnetic resonance imaging. Gynecol Oncol 1989;32(1):79-81.
41. Wegienka G, Baird DD, Hertz-Picciotto I, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 2003;101(3): 431-437.
42. Reich H. Laparoscopic myomectomy. Obstet Gynecol Clin North Am 1995;22(4):757-780.
43. Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynaecol 1991;98(4):385-389.
44. Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 2006;108(4):930-937.
45. Healy DL, Lawson SR, Abbott M, Baird DT, Fraser HM. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase. J Clin Endocrinol Metab 1986; 63(3):619-625.
46. Friedman AJ, Harrison-Atlas D, Barbieri RL, Benacerraf B, Gleason R, Schiff I. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril 1989;51 (2):251-256.
47. West CP, Lumsden MA, Lawson S, Williamson J, Baird DT. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril 1987;48 (1):45-51.
48. Worthington-Kirsch RL, Popky GL, Hutchins FL Jr. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 1998;208(3):625-629.
49. Spielmann AL, Keogh C, Forster BB, Martin ML, Machan LS. Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization. AJR Am J Roentgenol 2006;187(6):1499-1504.
50. Siskin GP. Uterine fibroid embolization: successful patient selection is difficult, but makes all the difference. Endovascular Today. http://www.evtodayarchive.com/03_archive/1102/071.html. Accessed March 15, 2008.
51. Verma SK, Bergin D, Gonsalves CF, Mitchell DG, Lev-Toaff AS, Parker L. Submucosal fibroids becoming endocavitary following uterine artery embolization: risk assessment by MRI. AJR Am J Roentgenol 2008;190(5):1220-1226.
52. Shlansky-Goldberg RD, Coryell L, Stavropoulos SW, et al. Outcomes following fibroid expulsion after uterine artery embolization. J Vasc Interv Radiol 2011;22(11):1586-1593.
53. Radeleff B, Eiers M, Bellemann N, et al. Expulsion of dominant submucosal fibroids after uterine artery embolization. Eur J Radiol 2010;75(1):e57-e63.
54. Nikolaidis P, Siddiqi AJ, Carr JC, et al. Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization. J Vasc Interv Radiol 2005;16(11):1465-1471.
55. Kroencke TJ, Scheurig C, Poellinger A, Gronewold M, Hamm B. Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome. Radiology 2010;255(3):834-841.
56. Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 2005;234 (3):948-953.
57. Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG. Risk factors for adenomyosis. Hum Reprod 1997;12(6):1275-1279.
58. Matalliotakis IM, Kourtis AI, Panidis DK. Adenomyosis. Obstet Gynecol Clin North Am 2003;30 (1):63-82.
59. Bazot M, Cortez A, Darai E, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 2001;16(11):2427-2433.
60. Kitamura Y, Allison SJ, Jha RC, Spies JB, Flick PA, Ascher SM. MRI of adenomyosis: changes with uterine artery embolization. AJR Am J Roentgenol 2006;186(3):855-864.
61. Jha RC, Takahama J, Imaoka I, et al. Adenomyosis: MRI of the uterus treated with uterine artery embolization. AJR Am J Roentgenol 2003;181(3): 851-856.
62. Tamai K, Koyama T, Saga T, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008;18(4):723-730.
63. Pelage JP, Cazejust J, Pluot E, et al. Uterine fibroid vascularization and clinical relevance to uterine fibroid embolization. RadioGraphics 2005;25(spec no):S99-S117.
64. Kitamura Y, Ascher SM, Cooper C, et al. Imaging manifestations of complications associated with uterine artery embolization. RadioGraphics 2005; 25(Spec No.):S119-S132.
65. Spies JB, Bruno J, Czeyda-Pommersheim F, Magee ST, Ascher SA, Jha RC. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005;106(5 pt 1):933-939.
66. Edwards RD, Moss JG, Lumsden MA, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007;356 (4):360-370.
67. Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004;230 (3):803-809.
68. Worthington-Kirsch RL, Spies JB, Myers ER, et al. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol 2005;106(1):52-59.
69. Verma SK, Gonsalves CF, Baltarowich OH, Mitchell DG, Lev-Toaff AS, Bergin D. Spectrum of imaging findings on MRI and CT after uterine artery embolization. Abdom Imaging 2010;35(1):118-128.
70. Worthington-Kirsch RL, Hutchins FL Jr, Berkowitz RP. Uterine interstitial gas after uterine artery embolization: a benign finding. J Vasc Interv Radiol 1999;14:181-185.
71. Shukla PA, Kumar A, Klyde D, Contractor S. Pyomyoma after uterine artery embolization. J Vasc Interv Radiol 2012;23(3):423-424.